All In Biotech

Drug Trial Radar · NCT04396574

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2

Last checked: Nov 20, 2026Latest source record: Jun 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 558 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

558

Actual

Start

Jun 30, 2020

Primary completion

Dec 4, 2025

Study completion Dec 4, 2025

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
May 20, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 6 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.

Conditions

  • Migraine

Interventions

  • LasmiditanDrug

    Administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With at Least One Treatment Emergent Adverse Events (TEAEs)Time frame: Baseline up to 12-month treatment period (Up to 12 Months)
  2. Number of Participants With Discontinuations Due to Adverse Events (AEs)Time frame: Baseline up to 12-month treatment period (Up to 12 Months)

Locations

134 sites in 15 countries. Site status is shown where the registry gives one.

  • Central Research Associates

    Birmingham, Alabama

  • Rehabilitation & Neurological Services

    Huntsville, Alabama

  • Phoenix Children's Hospital

    Phoenix, Arizona

  • Perseverance Research Center

    Scottsdale, Arizona

  • Center for Neurosciences

    Tucson, Arizona

  • Arkansas Children's

    Little Rock, Arkansas

  • Core Healthcare Group

    Cerritos, California

  • Miller Children's & Women's Hospital Long Beach

    Long Beach, California

  • Sensa Health

    Los Angeles, California

  • Orange County Research Institute - Ontario

    Ontario, California

  • Yale University School of Medicine

    New Haven, Connecticut

  • Children's National Medical Center

    Washington D.C., District of Columbia

  • Wolfson Children's Hospital

    Jacksonville, Florida

  • Clinical Neuroscience Solutions, Inc. dba CNS Healthcare

    Jacksonville, Florida

  • Biotech Pharmaceutical Group

    Miami, Florida

  • New Horizon Research Center

    Miami, Florida

  • Ezy Medical Research

    Miami Lakes, Florida

  • Suncoast Clinical Research, Inc.

    New Port Richey, Florida

  • Avanza Medical Research Center

    Pensacola, Florida

  • Clinical Research Center of Florida

    Pompano Beach, Florida

  • USF Health

    Tampa, Florida

  • ForCare Clinical Research

    Tampa, Florida

  • Palm Beach Neurology

    West Palm Beach, Florida

  • Pediatric Neurology P.A.

    Winter Park, Florida

  • Meridian Clinical Research, LLC

    Savannah, Georgia

  • Rophe Adult and Pediatric Medicine/SKYCRNG

    Union City, Georgia

  • Hawaii Pacific Neuroscience

    Honolulu, Hawaii

  • Medical Research Partners

    Ammon, Idaho

  • Velocity Clinical Research, Boise

    Meridian, Idaho

  • Chicago Headache Center and Research Institute

    Chicago, Illinois

  • Chicago Headache Center and Research Institute - Naperville

    Naperville, Illinois

  • Qualmedica Research, LLC

    Evansville, Indiana

  • Fort Wayne Neurological Center - West

    Fort Wayne, Indiana

  • Josephson Wallack Munshower Neurology, PC

    Indianapolis, Indiana

  • Deaconess Clinic - Gateway Health Center

    Newburgh, Indiana

  • Integrated Clinical Trial Services, Inc.

    West Des Moines, Iowa

  • Qualmedica Research, LLC

    Bowling Green, Kentucky

  • University of Kentucky Chandler Medical Center

    Lexington, Kentucky

  • Qualmedica Research, LLC

    Owensboro, Kentucky

  • Children's Hospital New Orleans

    New Orleans, Louisiana

Showing 40 of 134 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.